Industry Bulletins | September 5, 2018
UPMC Health Plan Announces Agreement For Vivitrol
UPMC Health Plan (UPMC) recently announced it has joined in a value-based contract with pharmaceutical company Alkermes for Vivitrol, an injected drug that helps to block opioid cravings. The contract was led by the Center for Value-Based Pharmacy Initiatives, a non-profit group that is part of UPMC’s Insurance Services Division.
With a value-based contract—according to statements from UPMC leadership—the focus shifts from paying for a drug to paying for results, overall benefiting the consumer’s health. The contract will accomplish this by linking reimbursement for Vivitrol with positive clinical outcomes among UPMC Health . . .